πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11933866

Magnetic resonance maps for analyzing brain tissue

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931481

Microporous annealed particle gel system

The Regents of the University of California Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931375

Treatment of amyotrophic lateral sclerosis (ALS)

VOYAGER THERAPEUTICS, INC. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931399

Compositions and methods for dengue virus chimeric constructions in vaccines

Takeda Vaccines, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931402

Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931343

CD73 inhibitors

Arcus Biosciences, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931421

Muscle targeting complexes and formulations for treating myotonic dystrophy

Dyne Therapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931338

Nitrilated psilocybin derivatives and methods of using

Enveric Biosciences Canada Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931340

Use of sublingual dexmedetomidine for the treatment of agitation

BioXcel Therapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931336

Enhancing autophagy or increasing longevity by administration of urolithins

Amazentis SA Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931453

Drug delivery device

Nano Precision Medical, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932624

MDM2 degraders and uses thereof

Kymera Therapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932633

KRas G12C inhibitors

Mirati Therapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931463

All-in-one fixed-dose combination for treating Helicobacter pylori infection

RedHill Biopharma Ltd. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931480

Microporous annealed particle gels and methods of use

The Regents of the University of California Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11933781

Fibrosis model and methods of use thereof

The Regents of the University of Colorado Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932617

Compound for use in retinal diseases

ZHUHAI UNITED LABORATORIES CO., LTD. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932867

Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932856

RNA targeting of mutations via suppressor tRNAs and deaminases

The Regents of the University of California Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932870

Compositions and methods for immune cell modulation in adoptive immunotherapies

Fate Therapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932851

Exon skipping compositions for treating muscular dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932852

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Benitec IP Holdings Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932726

Method of making releasable polymeric reagents

Nektar Therapeutics Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932695

Modified antibodies and related compounds, compositions and methods of use

Sensei Biotherapeutics, Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted